Chemicals

6-methyl-2-propan-2-yl-1H-pyrimidin-4-one

We are 6-methyl-2-propan-2-yl-1H-pyrimidin-4-one CAS:2814-20-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

CAS No: 2814-20-2

Product Name: 6-methyl-2-propan-2-yl-1H-pyrimidin-4-one

Other Name:

2-Isopropyl-6-methyl-4-hydroxypyrimidine

2-Isopropyl-6-methylpyrimidin-4(3H)-one

6-hydroxy-2-isopropyl-4-methylpyrimidine

6-methyl-2-(propan-2-yl)pyrimidin-4(1H)-one

4(1H)-Pyrimidinone,6-methyl-2-(1-methylethyl)

4-hydroxy-2-isopropyl-6-methyl-pyrimidine

6-methyl-2-(propan-2-yl)pyrimidin-4-ol

6-methyl-2-(1-methylethyl)pyrimidin-4(1H)-one

2-isopropyl-4-hydroxy-6-methylpyrimidine

2-Isopropyl-6-methyl-4(1H)-pyrimidinone

2-Isopropyl-6-methylpyrimidin-4-ol

2-Isopropyl-4-methyl-6-hydroxypyrimidine

2-Isopropyl-6-methyl-4-pyrimidinol

Density: 1.1±0.1 g/cm3

Boiling Point: 244.3±20.0 °C at 760 mmHg

Melting Point: 172-175 °C(lit.)

Molecular Formula: C8H12N2O

Molecular Weight: 152.194

Flash Point: 101.6±21.8 °C

Exact Mass: 152.094955

PSA: 46.01000

LogP: 0.50

Vapour Pressure: 0.0±0.5 mmHg at 25°C

Index of Refraction: 1.528

Specification

Appearance: White Crystal Solid

Assay: ≥99.0%

Loss on drying: ≤0.5%

Application

Intermediates of Diazinon CAS: 333-41-5.

Be used as pesticide intermediate, mainly used in the synthesis of the insecticide Diazinon.

Package: 25kg/drum, can also be designed according to customer requirements.

Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

6-methyl-2-propan-2-yl-1H-pyrimidin-4-one

Related News: From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.2-Amino-3,5-dichloropyridine CAS:4214-74-8 From the perspective of the corresponding formulation manufacturer, the drug substance needs to meet the requirements of impurities and stability. The production base must pass the international quality system certifications such as cGMP and EuGMP. At the same time, the drug substance company must have sufficient capacity.4101-68-2 Taking Minuo Huawei as an example, in 2016, the capacity utilization rate and production-sales ratio of its multiple drug substance varieties reached more than 90%. Therefore, domestic API companies have expanded their production capacity in recent years to meet the growing demand for APIs.(3S)-3-(4-Nitro-1-oxo-1,3-dihydro-2H-isoindol-2-yl)piperidine-2,6-dione CAS:827026-45-9 In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.

Product Name
5-[2-(dibenzylamino)acetyl]-2-hydroxybenzamide	View Details
alkyl (c12-c14) glycidyl ether Cas:68609-97-2	View Details
methyl 6-chloro-4-hydroxy-1,1-dioxo-2H-thieno[2,3-e]thiazine-3-carboxylate	View Details